2nd Annual Companion Diagnostics & Biomarkers 2019

DESCRIPTION

The BioTech Pharma Summit is proud to present the 2nd Annual Companion Diagnostics & Biomarkers 2019. This innovative B2B event will enable the participants to learn about the latest trends, developments, business models and strategies in the companion diagnostics & Biomarkers.

Over 100+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will be joining the Companion Diagnostics & Biomarkers 2019

Companion diagnostics market is growing due to continuous advancement in medical technology both for the diagnosis and the treatment of patients. Rise in the prevalence of diseases like cancer & HIV is fueling to the growth of companion diagnostics as it assist in determining the patient specific dose and drugs.

Over 20+ presentations and case studies focused on the key issues in Companion Diagnostics & Biomarkers. Join us at the Companion Diagnostics & Biomarkers 2019 in Porto

The 2nd Annual Companion Diagnostics & Biomarkers 2019 will provide valued information about new IVD regulations, Dx reimbursement strategy, market access strategy to ensure successful commercialization with pharma & biotech companies. We will also provide solutions to assist in all stages of CDx development from the biomarker discovery process through CDx commercialization.

We sincerely hope you are able to join us for this year’s meeting and be part of a new paradigm of precision medicine at the 2nd Annual Companion Diagnostics & Biomarkers 2019!

KEY PRACTICAL LEARNING POINTS

  • Methods and Strategies to Profile the tumor Microenvironment
  • Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
  • Liquid biopsy- the future of cancer diagnosis and precision medicine.
  • Latest US and EU CDx regulation and guidance
  • Genetic biomarker-based patient stratification in non-oncology
  • The future & challenges of precision medicine
  • Innovative biomarker-driven clinical trials
  • Understanding payer perspectives and RWE approaches
  • Recent Developments in Companion Diagnostics in Auto-immune Disease and Immunooncology
  • Strategic Partnerships for CDx – Challenges and Opportunities
  • The Challenge of Personalised Healthcare in Respiratory Disease
  • Diagnostic Strategies for Cancer Immune Therapies
  • Developing and Implementing Effective Biomarker Strategies for Immuno-Oncology Trials
  • Exosome-derived epigenetic biomarkers for saliva diagnostics
  • A global perspective on BRCA gene testing
  • Image-based CDx solutions
  • Development and Commercialization of Biomarker Assays for Therapeutic and Diagnostic Guidance
  • Genomics challenges from a single sample to large clinical studies

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed mem- bers of academic and government institutions.
Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:

  • Companion Diagnostics
  • Molecular Diagnostics
  • Personalized Healthcare
  • Clinical Development
  • Regulatory Affairs
  • Molecular Diagnostics
  • Biomarkers
  • Medical Sciences
  • Experimental Medicine
  • Translational Medicine
  • Immunology
  • Genomics
  • Insurers
  • Patient Advocates
  • Payers
  • Market Access
  • Medical Sciences
  • Commercialisation
  • Oncology
  • Non-oncology
  • Rare Diseases
  • Drug Development
  • Research

TICKET FEES

Individual Registration

Ticket FeesSuper Early bird*Early Bird*Discounted TicketNormal Ticket
Due DateUntil Oct. 19thUntil Nov. 30thUntil Jan. 10thAfter Jan. 10th
Industry Fee1495 Euros1695 Euros1795 Euros1995 Euros
Academic/Investor/NPO500 Euros600 Euros650 Euros850 Euros
Premium Package2800 Euros3000 Euros3250 Euros3550 Euros

*The 2nd Annual Companion Diagnostics & Biomarkers 2019 is an exclusive limited seat event. Super Early-Bird/Early bird tickets are non-refundable and subject to availability.

Group Registration:

Team DiscountsUntil October 19thUntil November 30thUntil January 10thAfter January 10th
2 Delegates10%5%----
3 Delegates15%10%5%--
4+ Delegates20%15%10%5%

Use the Coupon Code below and save your seat


Coupon CodesAcademic/NPO/InvestorIndustry FeePremium Package
Super Early BirdExpiredExpiredExpired
Early BirdACBI19INDB19PXBI18
Discounted TicketNot AvailableNot AvailableNot Available

*For Group registration or Sponsorship/Exhibition enquires, please use the contact form below.

Director, Biomarkers, Janssen (Johnson & Johnson), NL
Senior Director, Genomics Platform Project & Alliance Management at Broad Institute, US
Chair of the Department of Biostatistics at the Harvard School of Public Health, US
Scientific Regulatory Expert Biomedicines at Paul-Ehrlich-Institut (PEI), DE
Senior Scientist at the Austrian Institute of Technology, AT
Vice President, R&D, Clinical Sequencing Division at Thermo Fisher Scientific, US
Senior Biologist at Mironid, UK
Chief Business Officer at Just Biotherapeutics, US
Director at European Molecular Genetics Quality Network (EMQN), UK
Global head of healthcare partnerships at NVIDIA, US
Vice President of Market Access at Galapagos NV, USA
Manager Global Regulatory Affairs, Biomarkers and Diagnostics at Merck, DE
Vice President, Development and Operations at Biodesix, Inc., US
Executive Director at BloodPAC, US
Senior Medical Oncologist & Professor of Medicine at Institut Curie & UVSQ, FR
Director Healthcare Systems at Novartis, CH
Chief Commercial Officer at Genomics England, UK
Vice President MHS global IVD at TÜV SÜD, JP
Professor of Translational Science, UCD School of Medicine, University College Dublin, IE
Vice President Translational Medicine at Pierre Fabre, FR
Executive Director, Personalised Healthcare and Biomarkers at AstraZeneca, UK
Professor in Molecular Oncology at Barts Cancer Institute, Queen Mary University of London, UK
Lawyer at Covington & Burling, BE
Senior Lecturer at Institute of Translational Medicine, University of Liverpool, UK
Chairman of the Nuclear Medicine Awareness Working Group from AIPES, BE
Industry Package
1,995
Buy Ticket

Full access to Presentations

Full access to Networking sessions

One-on-One Meetings

Business Lunches

Premium Package
3,550
Buy Ticket

Full Access to Both Streams: CDx & Biomarkers + Biobanking

VIP Airport Pick-Up

One-on-One Meetings

Accommodation in Superior Room

Academic Package
850
Buy Ticket

Full access to Presentations

Full access to Networking sessions

Business Lunches

Exhibition Package
3,550
Buy Ticket

3m2 Exhibition Space

Full Access to Industry Package

Book Bag Inserts

Gala Dinner